Search

Issue
Title
Authors
THE POSSIBILITIES AND MECHANISMS OF ACTION OF HORMONE THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER
Alekseev B.Y., Andrianov A.N.
The National Registry of treatment regimens in patients with metastatic castration-resistant prostate cancer in the Russian Federation
Karyakin O.B., Kaprin A.D., Ivanov S.A.
Pharmacoeconomic analysis of enzalutamide and abiraterone for treatment of chemotherapy naive patients with metastatic castration resistant prostate cancer
Avxentyev N.A., Frolov M.Y., Makarov A.S.
Pharmacoeconomic aspects of using enzalutamide and abiraterone for treatment of chemotherapy-naive patients with metastatic castration-resistant prostate cancer
Avxentyev N.A., Frolov M.Y., Makarova Y.V.
Chemotherapy in the treatment of metastatic prostate cancer: the present state of the problem
Alekseev B.Y.
Metastatic hormone-sensitive prostate cancer: Practical guidelines and optimization of therapy selection
Gafanov R.A., Dzidzaria A.G., Kravtsov I.B., Fastovets S.V.
Predictors of overall survival in patients with metastatic castration-resistant prostate cancer
Markova A.S., Polikarpova S.B., Kamolov B.S., Gridneva Y.V., Kalinin S.A., Peters M.V., Matveev V.B.
Radionuclide therapy with radium-223 chloride. A few strokes to the patient’s portrait
Oschepkov V.N., Zotov P.B., Ismakov R.M., Khazimov A.M., Tukmanbetov I.D.
Cost-effectiveness of abiraterone treatment in patients with castration-resistant prostate cancer who previously received docetaxel therapy
Rudakova A.V., Meshkov D.O., Mishugin S.V.
SEQUENTIAL THERAPY OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: NEW POSSIBILITIES
Markova A.S., Matveev V.B., Nazranov B.M.
Efficacy of novel androgen axis inhibitors for the treatment of hormone-sensitive prostate cancer in patients with visceral metastases: a systematic review and meta-analysis
Murazov I.G., Prokhorov D.G., Tareev Y.S., Smirnov R.V.
REVIEW OF THE ONCOLOGICAL UROLOGY PROCEEDINGS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) 2018 ANNUAL MEETING
Kirichek A.A., Kamolov B.S., Matveev V.B., Nazranov B.M.
CURRENT POSSIBILITIES OF DRUG THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER
Markova A.S.
Efficacy and safety of radium-223 in routine clinical practice
Matveev V.B., Markova A.S.
Efficacy and safety of enzalutamide, abiraterone and cabazitaxel in post-docetaxel treatment of castration-resistant prostate cancer: meta-analysis data
Mazin P.V., Mazina N.K.
CURRENT POSSIBILITIES OF TREATMENT FOR VISCERAL METASTASES IN PATIENTS WITH METASTATIC CASTRATION-REFRACTORY PROSTATE CANCER
Govorov A.V., Moiseenko T.N.
Replacing prednisolone with dexamethasone to overcome the resistance to abiraterone in castration-resistant prostate cancer: a clinical case
Meshcheryakov A.A., Gordeeva O.O.
Current approaches to selection of the 1st line therapy in patients with metastatic hormone-sensitive prostate cancer
Alekseev B.Y., Andrianov A.N., Kaprin A.D.
1 - 18 of 18 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"